Ad
related to: boston scientific acquisition history report requestEnables Intelligent & Data-Driven Decision Making - FinancesOnline.com
- M&A Market News
Explore our latest coverage on the
mergers and acquisition space.
- Deals Data
See detailed data on deals
in the private and public markets.
- Request a Free Trial
Experience PitchBook firsthand
and how our data can benefit you.
- Female Founders Dashboard
VC funding surges but the number of
female founders lags behind
- Morningstar Research
Morningstar is a leading provider
of independent investment research.
- M&A Deal Data
Get insight into valuable and up to
date M&A deals in any industry.
- M&A Market News
Search results
Results From The WOW.Com Content Network
The next day, Boston Scientific increased their bid to $25 billion, followed the next day by Johnson & Johnson increasing their bid to $24.2 billion. It was not until January 17 that Boston Scientific produced a new offer of $27.2 billion ($80 per share), with the help of Abbott Laboratories. Abbott agreed to purchase $1.4 billion of Boston ...
Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware, [2] is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...
Boston Scientific has made a strong move deeper into the business of electrophysiology -- the study of electrical phemomena, and how they are related to the functions of the body. The company ...
With the lower re-negotiated a lower price of $21.5 billion between Johnson & Johnson and Guidant, Boston Scientific announced an unsolicited offer of $24.6 billion for Guidant (an offer of $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share).
BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changed its name on 27 May 1998. [2]
Boston Scientific forecast a full-year profit on Wednesday that was largely ahead of analysts' estimates and said the U.S. health regulator has approved its heart device, sending the company's ...
They borrowed $800,000 to start Boston Scientific, a manufacturer of medical devices. He helped grow the company through a series of astute acquisitions. [6] Nicholas was chief executive officer of the company until 1999, when he became chairman. He continued in that role until his retirement in 2016. [3]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Boston_Scientific_Corporation&oldid=19811070"
Ad
related to: boston scientific acquisition history report request